Low-level primary clarithromycin resistance of Helicobacter pylori in Burkina Faso: A prospective molecular study

Helicobacter. 2019 Feb;24(1):e12551. doi: 10.1111/hel.12551. Epub 2018 Nov 12.
No abstract available

Keywords: antimicrobial susceptibility; eradication; macrolide; therapeutic regimens.

Publication types

  • Letter

MeSH terms

  • Burkina Faso
  • Clarithromycin / pharmacology*
  • Clarithromycin / therapeutic use
  • Drug Resistance, Bacterial / genetics*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / genetics
  • Humans
  • Microbial Sensitivity Tests
  • Point Mutation
  • RNA, Ribosomal, 23S / genetics

Substances

  • RNA, Ribosomal, 23S
  • Clarithromycin

Grants and funding